The store will not work correctly when cookies are disabled.
Ethyl 2-methyl-5-(pyrrolidin-1-yl)furo[2,3-b]pyridine-3-carboxylate
ID: ALA4525344
PubChem CID: 132527228
Max Phase: Preclinical
Molecular Formula: C15H18N2O3
Molecular Weight: 274.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1c(C)oc2ncc(N3CCCC3)cc12
Standard InChI: InChI=1S/C15H18N2O3/c1-3-19-15(18)13-10(2)20-14-12(13)8-11(9-16-14)17-6-4-5-7-17/h8-9H,3-7H2,1-2H3
Standard InChI Key: QMKCXFZKBXKVCB-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
29.5330 -9.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5319 -10.6382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2399 -11.0471 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2381 -9.4098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9468 -9.8150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9516 -10.6337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7316 -10.8821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2089 -10.2170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7238 -9.5576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1339 -8.8515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9511 -8.8541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7276 -8.1425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.0261 -10.2122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1384 -7.4361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9556 -7.4387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8251 -9.4110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8250 -8.5930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0471 -8.3403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5663 -9.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0472 -9.6638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
10 12 1 0
8 13 1 0
12 14 1 0
14 15 1 0
1 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 274.32 | Molecular Weight (Monoisotopic): 274.1317 | AlogP: 2.91 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.57 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.41 | CX LogP: 2.36 | CX LogD: 2.36 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.81 | Np Likeness Score: -1.27 |
References
1. Fumagalli F, de Melo SMG, Ribeiro CM, Solcia MC, Pavan FR, da Silva Emery F.. (2019) Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis., 29 (8): [PMID:30803803] [10.1016/j.bmcl.2019.02.019] |